OPPENHEIMER & CO INC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 822581 NEW YORK, NY

Position in CPRX

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$1,686,552

-$810,314 QoQ

Shares Held

68,116

-36.3% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OPPENHEIMER & CO INC holds $44,352,224 across 44 Biotechnology names. CPRX ranks #6 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	22,477	$17,366,629
2	VKTX	Viking Therapeutics, Inc.	150,133	$4,885,327
3	TYRA	Tyra Biosciences, Inc.	84,192	$3,224,553
4	CAPR	Capricor Therapeutics, Inc.	63,666	$1,935,446
5	VRTX	Vertex Pharmaceuticals Inc / Ma	4,308	$1,923,694
6	CPRX	Catalyst Pharmaceuticals, Inc. This page	68,116	$1,686,552
7	NTLA	Intellia Therapeutics, Inc.	106,924	$1,370,765
8	TRVI	Trevi Therapeutics, Inc.	100,027	$1,193,322

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,686,552	68,116	-36.3%	Shares	Sole	2026-04-24
2025-12-31	$2,496,866	106,978	+16.3%	Shares	Sole	2026-02-02
2025-09-30	$1,811,946	91,977	-10.9%	Shares	Sole	2025-11-06
2025-06-30	$2,240,959	103,270	+4.6%	Shares	Sole	2025-07-31
2025-03-31	$2,394,590	98,746	-5.5%	Shares	Sole	2025-04-23
2024-12-31	$2,180,643	104,487	+28.3%	Shares	Sole	2025-02-05
2024-09-30	$1,618,410	81,409	-6.1%	Shares	Sole	2024-11-05
2024-06-30	$1,343,339	86,723	+71.6%	Shares	Sole	2024-08-08
2024-03-31	$805,464	50,531	—	Shares	Sole	2024-05-07
No filing history on record for this holder in this stock.